1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Retroviral mediated transfer and expression of the human glucose 6-phosphate dehydrogenase (G6PD) gene
    Meeting Abstract

    Rovira, A.; Wong, A.; Sadelain, M.; Luzzatto, L.
    Blood (1996)

    Fulltext@MSK | Save
  • Vaccination of patients with chronic myelogenous leukemia using leukemia-specific BCR-ABL breakpoint fusion peptides
    Meeting Abstract

    Scheinberg, D. A.; Bocchia, M.; Koronstvit, T.; Caggiano, J.; Weiss, M.; Kolitz, J.; Megherian, L.; George, D.
    Blood (1996)

    Fulltext@MSK | Save
  • Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: Long-term follow-up in acute promyelocytic leukemia (APL)
    Meeting Abstract

    Jurcic, J. G.; Miller, W. H. Jr; DeBlasio, A.; Scheinberg, D. A.; Warrell, R. P. Jr
    Blood (1996)

    Fulltext@MSK | Save
  • Construction of a single chain antibody targeting the human myeloid cell antigen CD33
    Meeting Abstract

    Chang, E.; Soong, N.; Scheinberg, D. A.; Anderson, F. A.; Douer, D.
    Blood (1996)

    Fulltext@MSK | Save
  • Current results of donor leukocyte infusions (DLI) for treatment of Epstein-Barr virus associated lymphoproliferative disorders (EBVLPD) following related and unrelated T cell depleted bone marrow transplant (TCDBMT)
    Meeting Abstract

    Papadopoulos, E. B.; Small, T.; Ladanyi, M.; Boulad, F.; Castro-Malaspina, H.; Childs, B.; Kernan, N.; Mackinnon, S.; Szabolcs, P.; Young, J.; more...
    Blood (1996)

    Fulltext@MSK | Save
  • Platelet sensitivity to tapering doses of cyclosporin-A (CSA) in children with severe aplastic anemia (SAA)
    Meeting Abstract

    George, D.; Gillio, A.; Van Syckle, K.; Kernan, N.; Small, T.; Szabolcs, P.; Castro Malaspina, H.; Williams, T.; O'Reilly, R.; Boulad, F.
    Blood (1996)

    Fulltext@MSK | Save
  • Monosomy 7 predicts a poor outcome after allogeneic bone marrow transplantation (BMT)
    Meeting Abstract

    Boulad, F.; Castro-Malaspina, H.; Papadopoulos, E.; Childs, B.; Gillio, A.; Kernan, N.; Small, T.; Szabolcs, P.; Taylor, J.; Van Syckle, K.; more...
    Blood (1996)

    Fulltext@MSK | Save
  • Allogeneic bone marrow transplantation (allo-BMT) or autologous BMT (ABMT) for the treatment of pediatric patients with non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Boulad, F.; Gillio, A.; Gardner, S.; Kernan, N.; Small, T.; Van Syckle, K.; Williams, T.; Yahalom, J.; O'Reilly, R.
    Blood (1996)

    Fulltext@MSK | Save
  • Retroviral transduction of human hematopoietic progenitor cells using a vector encoding a cell surface marker (LNGFR) to optimize transgene expression and characterize transduced cell populations
    Meeting Abstract

    Leonard, J. P.; May, C.; Gallardo, H.; Rafii, S.; Sadelain, M.; Moore, M. A. S.
    Blood (1996)

    Fulltext@MSK | Save
  • Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy
    Meeting Abstract

    Weiss, M.; Glenn, M.; Maslak, P.; Rahman, Z.; Megherian, L.; Noy, A.; Zelenetz, A.; Scheinberg, D.; Golde, D.
    Blood (1996)

    Fulltext@MSK | Save